Search alternatives:
values decrease » values increased (Expand Search), largest decrease (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
ad cases » all cases (Expand Search), 19 cases (Expand Search), _ cases (Expand Search)
i values » _ values (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
Showing 81 - 100 results of 25,407 for search '(((( c large decrease ) OR ( ((chd cases) OR (ad cases)) increased ))) OR ( i values decrease ))', query time: 1.06s Refine Results
  1. 81
    Costs and Benefits of Popular <i>P</i>‑Value Correction Methods in Three Models of Quantitative Omic Experiments

    Costs and Benefits of Popular <i>P</i>‑Value Correction Methods in Three Models of Quantitative Omic Experiments by Steven R. Shuken (14500192)

    Published 2023
    “…We show how increasing sample size, decreasing variability, or increasing effect size can enable the detection of all true changes while still correcting <i>p</i>-values, and we present basic guidelines for omic experimental design. …”
    Save to List
    Saved in:
  2. 82
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  3. 83
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  4. 84
    Same as Fig 2A but for DENV 3, without fine resolution added.

    Same as Fig 2A but for DENV 3, without fine resolution added. by Shaowei Sang (520418)

    Published 2021
    Save to List
    Saved in:
  5. 85
    Species occurrence along the NO₃¯ gradient (sorted by decreasing 25th percentile values).

    Species occurrence along the NO₃¯ gradient (sorted by decreasing 25th percentile values). by Willem Kaijser (12872371)

    Published 2022
    Save to List
    Saved in:
  6. 86
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  7. 87
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  8. 88
    Mean values of “I feel bored” item.

    Mean values of “I feel bored” item. by Ezel Üsten (16548547)

    Published 2023
    Save to List
    Saved in:
  9. 89
    Age and Gender distribution of study participants.

    Age and Gender distribution of study participants. by Radha Joshi (22411067)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 90
    Data cleaning for Nutritional Status analysis.

    Data cleaning for Nutritional Status analysis. by Radha Joshi (22411067)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 91
    Supplementary material.

    Supplementary material. by Radha Joshi (22411067)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 92
    Birth weight and nutrition status.

    Birth weight and nutrition status. by Radha Joshi (22411067)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 93
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  14. 94
    Refinement of scrambles, with no USM decreases.

    Refinement of scrambles, with no USM decreases. by Jedediah M. Singer (10331212)

    Published 2022
    Save to List
    Saved in:
  15. 95
    Determination of p-values by permutation tests.

    Determination of p-values by permutation tests. by Sarah A. Johnson (11355817)

    Published 2021
    Save to List
    Saved in:
  16. 96
    Increases and decreases in resources.

    Increases and decreases in resources. by Guangliang Li (194029)

    Published 2024
    Save to List
    Saved in:
  17. 97
    Under-five, post-neonatal and child mortality among children admitted to pediatrics ward of Asella Teaching and Referral Hospital, January 2020 G.C.

    Under-five, post-neonatal and child mortality among children admitted to pediatrics ward of Asella Teaching and Referral Hospital, January 2020 G.C. by Firaol Lemessa Kitila (11402219)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  18. 98
    Effect of systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) on total coronary heart disease (CHD) at different ages.

    Effect of systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) on total coronary heart disease (CHD) at different ages. by Nelson Wang (8174217)

    Published 2023
    Save to List
    Saved in:
  19. 99
    Effect of systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) on incident coronary heart disease (CHD) at different ages.

    Effect of systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) on incident coronary heart disease (CHD) at different ages. by Nelson Wang (8174217)

    Published 2023
    Save to List
    Saved in:
  20. 100
    Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade

    Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade by Serisha D. Naicker (8648370)

    Published 2020
    Save to List
    Saved in:

Search Tools: